US SB3945 | 2019-2020 | 116th Congress

Status

Spectrum: Partisan Bill (Republican 3-0)
Status: Introduced on June 11 2020 - 25% progression, died in committee
Action: 2020-06-11 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Allows accelerated depreciation of nonresidential real property acquired to relocate facilities for the manufacture of pharmaceuticals and medical devices or supplies in the United States. It also allows an exclusion from gross income of gain from the sale or exchange of relocation property that was used to manufacture medical products in a foreign country.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Bring Entrepreneurial Advancements To Consumers Here In North America Act

Sponsors


History

DateChamberAction
2020-06-11SenateRead twice and referred to the Committee on Finance.

Same As/Similar To

HB6690 (Related) 2020-05-01 - Referred to the House Committee on Ways and Means.

Subjects


US Congress State Sources


Bill Comments

feedback